Principal Analyst- Financial Consolidation jobs in United States
cer-icon
Apply on Employer Site
company-logo

Medtronic · 2 days ago

Principal Analyst- Financial Consolidation

Medtronic is a global healthcare technology company committed to alleviating pain and restoring health. The Principal Analyst will support day-to-day accounting and financial reporting for the Diabetes Operating Unit, ensuring compliance with US GAAP and supporting the financial close process.

Artificial Intelligence (AI)BiotechnologyHealth CareHealth DiagnosticsMedical Device
check
H1B Sponsor Likelynote

Responsibilities

Deliver timely period-end closing for month end, quarter end, and year end, working closely with Financial Shared Services and support functions
Deliver financial close and reporting in compliance with US GAAP and local statutory financial standards
Compile and analyze financial information to record transactions, prepare reports, and verify accuracy
Prepare journal entries and balance sheet account reconciliations; strengthen balance sheet controls
Work with external auditors and tax consultants to support on-time statutory audits, corporate tax, and indirect tax filings
Support internal control requirements, including SOX compliance
Support legal-entity fiduciary responsibilities as needed
Provide technical accounting support for M&A transactions impacting the Diabetes Operating Unit
Oversee technical accounting research for complex business transactions and new accounting standard implementations
Support continuous improvement initiatives and ad-hoc finance and reporting projects
Support duties related to the diabetes division separation effort for Day-1 readiness of the Record-to-Report workstream

Qualification

US GAAPFinancial reportingTechnical accountingCPAFinancial consolidationAudit coordinationProcess improvementM&A transactionsSoft skills

Required

Bachelor's Degree and 7+ years experience as financial analyst, accounting, business analyst or other relevant field
OR Advanced Degree and 5+ years experience as financial analyst, accounting, business analyst or other relevant field

Preferred

10+ years of progressive experience in external financial reporting within a public company and/or Big 4 environment
Strong understanding of U.S. GAAP, SEC reporting requirements, and disclosure controls
Hands-on experience preparing or reviewing Form 10-K, 10-Q, 8-K, and earnings release materials
Exposure to technical accounting research and coordination with audit and legal functions
Proven ability to interpret complex accounting topics and translate them into clear, concise disclosures
Strong command of financial consolidation and reporting platforms (e.g., OneStream and Workiva)
Experience working in a newly public or transformation-driven environment
CPA or MBA preferred

Benefits

Health, Dental and vision insurance
Health Savings Account
Healthcare Flexible Spending Account
Life insurance
Long-term disability leave
Dependent daycare spending account
Tuition assistance/reimbursement
Simple Steps (global well-being program)
Incentive plans
401(k) plan plus employer contribution and match
Short-term disability
Paid time off
Paid holidays
Employee Stock Purchase Plan
Employee Assistance Program
Non-qualified Retirement Plan Supplement (subject to IRS earning minimums)
Capital Accumulation Plan (available to Vice Presidents and above, or subject to IRS earning minimums)

Company

Medtronic

company-logo
Medtronic is a healthcare technology company that designs and develops AI-based products and solutions for the medical industry.

H1B Sponsorship

Medtronic has a track record of offering H1B sponsorships. Please note that this does not guarantee sponsorship for this specific role. Below presents additional info for your reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (349)
2024 (387)
2023 (291)
2022 (310)
2021 (300)
2020 (261)

Funding

Current Stage
Public Company
Total Funding
$18.16B
Key Investors
NHS EnglandBlackstone Life SciencesTrade Capital Funding
2025-09-15Post Ipo Debt· $1.76B
2024-05-29Post Ipo Debt· $3.24B
2023-03-23Post Ipo Debt· $2B

Leadership Team

leader-logo
Geoffrey Martha
CEO and Chairman Of The Board Of Directors
linkedin
leader-logo
Linnea Burman
SVP & President, Neurovascular
linkedin
Company data provided by crunchbase